Stockreport

SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds [Yahoo! Finance]

Clearmind Medicine Inc.  (CMND) 
PDF company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of its ongoing collabor [Read more]